Progesterone
- Generic Name
- Progesterone
- Brand Names
- Bijuva, Crinone, Endometrin, Prochieve, Prometrium
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 57-83-0
- Unique Ingredient Identifier
- 4G7DS2Q64Y
- Background
Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prev...
- Indication
Gelatinized capsules
The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .
Vaginal gel
...
- Associated Conditions
- Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
- Associated Therapies
- Assisted Reproductive Technology therapy
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
- Conditions
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 784
- Registration Number
- NCT04414761
- Locations
- 🇨🇳
ShangHai JIAI Genetics&IVF Institute, Shanghai, China
Serum Progesterone on the Day of Thawed Embryo Transfer and Pregnancy Rate After an Artificial Endometrial Preparation
- First Posted Date
- 2020-02-20
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Hillel Yaffe Medical Center
- Target Recruit Count
- 38
- Registration Number
- NCT04278508
- Locations
- 🇮🇱
Hillel Yaffe Medical Center, Hadera, Israel
Neurobiology of Bulimia Nervosa
- Conditions
- Interventions
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 10
- Registration Number
- NCT04225221
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Endometrial Heparin-binding Epidermal Growth Factor Expression
- Conditions
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- National University of Malaysia
- Target Recruit Count
- 40
- Registration Number
- NCT04175002
- Locations
- 🇲🇾
Medically Assisted clinic in Obstetrics & Gynaecology department, UKM Medical Centre, Cheras, Kuala Lumpur, Malaysia
Progesterone in the Treatment of Acute Hemorrhagic Stroke
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2019-11-27
- Target Recruit Count
- 184
- Registration Number
- NCT04143880
Progesterone and Resting Energy Expenditure
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 2
- Registration Number
- NCT04140968
- Locations
- 🇨🇭
Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern, Berne, Switzerland
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
- Conditions
- Interventions
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Institut Universitari Dexeus
- Target Recruit Count
- 44
- Registration Number
- NCT04108039
- Locations
- 🇪🇸
Institut Universitari Dexeus, Barcelona, Catalunya, Spain
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
- First Posted Date
- 2019-08-09
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 23
- Registration Number
- NCT04051320
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
- Conditions
- Interventions
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2019-08-06
- Lead Sponsor
- Shanghai First Maternity and Infant Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04046185
Progesterone Versus Progesterone Plus Dydrogesterone in FET
- Conditions
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Mỹ Đức Hospital
- Target Recruit Count
- 1364
- Registration Number
- NCT03998761
- Locations
- 🇻🇳
Mỹ Đức Hospital, Ho Chi Minh City, Tan Binh, Vietnam
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.